Association between adult height, genetic susceptibility and risk of glioma

International Journal of Epidemiology

Volumn 41, Issue 4, 2012, Pages 1075-1085

  Kitahara, Cari M ^a   Wang, Sophia S ^b   Melin, Beatrice S ^c   Wang, Zhaoming ^a,d   Braganza, Melissa ^a   Inskip, Peter D ^a   Albanes, Demetrius ^a   Andersson, Ulrika ^c   Beane freeman, Laura E ^a   Buring, Julie E ^e   Carreón, Tania ^f   Feychting, Maria ^g   Gapstur, Susan M ^h   Gaziano, J Michael ^e,i   Giles, Graham G ^j,k   Hallmans, Goran ^c   Hankinson, Susan E ^e   Henriksson, Roger ^c,l   Hsing, Ann W ^a   Johansen, Christoffer ^m   Linet, Martha S ^a   Mckean cowdin, Roberta ⁿ   Michaud, Dominique S ^o   Peters, Ulrike ^p,q   Purdue, Mark P ^a   Rothman, Nathaniel ^a   Ruder, Avima M ^f   Sesso, Howard D ^e   Severi, Gianluca ^j,k   Shu, Xiao Ou ^r   Stevens, Victoria L ^h   Visvanathan, Kala ^s,t   Waters, Martha A ^f   White, Emily ^p,q   Wolk, Alicja ^g   Zeleniuch jacquotte, Anne ^u   Zheng, Wei ^r   Hoover, Robert ^a   Fraumeni, Joseph F ^a   Chatterjee, Nilanjan ^a   Yeager, Meredith ^a,d   Chanock, Stephen J ^a,d   Hartge, Patricia ^a   Rajaraman, Preetha ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

^d SAIC FREDERICK INC   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^g KAROLINSKA INSTITUTE   (Sweden)

^h AMERICAN CANCER SOCIETY   (United States)

ⁱ GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^j CANCER EPIDEMIOLOGY CENTRE   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^m DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

ⁿ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^o BROWN UNIVERSITY   (United States)

^p Fred Hutchinson Cancer Research Center   (United States)

^q UNIVERSITY OF WASHINGTON   (United States)

^r VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^s JOHNS HOPKINS UNIVERSITY   (United States)

^t JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^u NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Brain cancer; Cancer; Epidemiology; Glioma; Height

Indexed keywords

ADULT; BRAIN; CANCER; COHORT ANALYSIS; EPIDEMIOLOGY; GENETIC VARIATION; HEALTH RISK; HEIGHT; LOGISTICS; PUBLIC HEALTH; REGRESSION ANALYSIS;

ARTICLE; BODY HEIGHT; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; BODY HEIGHT; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLIOMA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865725722     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dys114     Document Type: Article

References (47)

1. CBTRUS. Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008. Hinsdale, IL: Central Brain Tumor Registry of the United States, 2012.
2. Preston-Martin S, Munir R, Chakrabarti I. Nervous system. In: Schottenfeld D, Fraumeni JF (eds). Cancer Epidemiology and Prevention. 3rd edn. Oxford: Oxford University Press, 2006, pp. 1173-995.
3. Shete S, Hosking FJ, Robertson LB et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009;41:899-904.
4. Wrensch M, Jenkins RB, Chang JS et al. Variants in the CDKN2B and RTEL1 regions are associated with highgrade glioma susceptibility. Nat Genet 2009;41:905-08.
5. Sanson M, Hosking FJ, Shete S et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 2011;20:2897-904.
6. Helseth A, Tretli S. Pre-morbid height and weight as risk factors for development of central nervous system neoplasms. Neuroepidemology 1989;8:277-82.
7. Moore SC, Rajaraman P, Dubrow R et al. Height, body mass index, and physical activity in relation to glioma risk. Cancer Res 2009;69:8349-55.
8. Benson VS, Pirie K, Green J et al. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 2008;99:185-90.
9. Sung J, Song YM, Lawlor DA, Davey Smith G, Ebrahim S. Height and site-specific cancer risk: a cohort study of a Korean adult population. Am J Epidemiol 2009;170:53-64.
10. Batty GD, Barzi F, Woodward M et al. Asia Pacific cohort studies collaboration. Adult height and cancer mortality in Asia: the Asia Pacific cohort studies collaboration. Ann Oncol 2010;21:646-54.
11. Michaud DS, Bove G, Gallo V et al. Anthropometric measures, physical activity and risk of glioma and meningioma in a large prospective cohort study. Cancer Prev Res (Phila) 2011;4:1385-92.
12. Lango Allen H, Estrada K, Lettre G et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010;467:832-38.
13. Gunnell D, Okasha M, Davey Smith G, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001;23:313-42.
14. Schroeder DG, Martorell R, Rivera JA, Ruel MT, Habicht JP. Age differences in the impact of nutritional supplementation on growth. J Nutr 1995;125: 1051S-59S.
15. Kusin J, Kardjati S, Houtkooper J, Renqvist U. Energy supplementation during pregnancy and postnatal growth. Lancet 1992;340:623-26.
16. Butler NR, Goldstein H. Smoking in pregnancy and subsequent child development. Br Med J 1973;4:573-75.
17. Malleson P. Pain syndromes, disability and chronic disease in childhood. Curr Opin Rheumatol 1991;3:860-66.
18. Batty GD, Shipley MJ, Gunnell D et al. Height, wealth, and health: an overview with new data from three longitudinal studies. Econ Hum Biol 2009;7:137-52.
19. Alavanja MC, Sandler DP, McMaster SB et al. The agricultural health study. Environ Health Perspect 1996;104: 362-69.
20. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance: the ATBC Cancer Prevention Study Group. Ann Epidemiol 1994;4:1-10.
21. Gallichio L, Chang H, Christo DK et al. Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland. Am J Epidemiol 2008; 167:807-13.
22. Calle E, Rodriguez C, Jacobs EJ et al. The American cancer society cancer prevention study ii nutrition cohort-rationale, study design and baseline characteristics. Cancer 2002;94:2490-501.
23. Giles GG, English DR. The Melbourne collaborative cohort study. IARC Sci Publ 2002;156:69-70.
24. Kolonel LN, Henderson BE, Hankin JH et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346-57.
25. Hatch EE, Linet MS, Zhang J et al. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 2005;114:797-805.
26. Ruder AM, Waters MA, Carreon T et al. The upper midwest health study: a case-control study of primary intracranial gliomas in farm and rural residents. J Agric Saf Health 2006;12:255-74.
27. Hallmans G, Agren A, Johansson A et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort-evaluation of risk factors and their interactions. Scand J Public Health Suppl 2009;61: 18-24.
28. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995;87: 190-97.
29. Steering Committee of the Physicians' Health Study Research Group. Final report of the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-35.
30. Hayes RB, Reding D, Kopp W et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000; 21:349S-55S.
31. Zheng W, Chow WH, Yang G et al. The Shanghai women's health study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-31.
32. Cai H, Zheng W, Xiang YB et al. Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai men's health study. Br J Nutr 2007;98:1006-13.
33. White E, Patterson RE, Kristal AR et al. VITamins and Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol 2004;159:83-93.
34. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the women's health study. J Womens Health Gend Based Med 2000;9:19-27.
35. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39: 906-13.
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
37. Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR. Adult stature and risk of cancer. Cancer Res 1988;48:1658-62.
38. Hebert PR, Ajani U, Cook NR, Lee IM, Chan KS, Hennekens CH. Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 1997;8:591-97.
39. Green J, Cairnes BJ, Casabonne D et al. Height and cancer incidence in the Million Women study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 2011;12: 785-94.
40. Hauspie RC, Vercauteren M, Susanne C. Secular changes in growth and maturation: an update. Acta Paediatr Suppl 1997;423:20-27.
41. Juul A, Bang P, Hertel NT et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-52.
42. Crowe FL, Key TJ, Allen NE et al. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1-2 and -3 in the European prospective investigation into cancer and nutrition (EPIC). Ann Hum Biol 2011;38:194-202.
43. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 2010;61:301-16.
44. Lönn S, Inskip PD, Pollack MN, Weinstein SJ, Virtamo J, Albanes D. Glioma risk in relation to serum levels of insulin-like growth factors. Cancer Epidemiol Biomarkers Prev 2007;16:844-46.
45. Sorkin JD, Muller DC, Andres R. Longitudinal change in the heights of men and women: consequential effects on body mass index. Epidemiol Rev 1999;21:247-60.
46. Kuczmarski MF, Kuczmarski RJ, Najjar M. Effects of age on validity of self-reported height, weight, and body mass index: findings from the third national health and nutrition examination survey, 1988-1994. J Am Diet Assoc 2001; 101:28-34.
47. Gunnell DJ, Davey Smith G, Frankel S et al. Childhood leg length and adult mortality: follow up of the Carnegie (Boyd Orr) survey of diet and health in pre-war Britain. J Epidemiol Community Health 1998;52:142-52.